SEATTLE - Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company with a market capitalization of $120 million and an impressive 13% gain over the past week, has announced ...

I used to be you!” I wanted to cry out. “Do a self-breast check!” Just one year before, I often wore that very same “HEALTH!” shirt, back when I thought health was something you could buy and show off ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ...